Key benefits of dexamethasone and antibody treatment in COVID-19 hamster models revealed by single-cell transcriptomics
COVID-19 햄스터 모델에서 덱사메타손 및 항체 치료의 주요 이점, 단일 세포 전사체로 밝혀짐
Article
Published on
Journal: Molecular therapy : the journal of the American So [Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘, 진단, 치료법, 치료제,
Journal: Molecular therapy : the journal of the American So [Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘, 진단, 치료법, 치료제,
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
Analysis
analyzed
Anti-inflammatory
anti-inflammatory effect
anti-inflammatory properties
anti-inflammatory property
anti-SARS-CoV-2 antibody
Anti-viral
anti-viral effect
anti-viral effects
antibodies
antibody
antibody treatment
benefit
Cell
combination therapy
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 treatment
Dexamethasone
disease
drugs
Effect
effective
Efficacy
exhibited
hamster
host responses
immune responses
Immunity
Infection
Inflammatory
inflammatory cell
lung
Lungs
mechanisms
monoclonal antibody
monoclonal antibody therapy
Neutrophils
potential mechanism
prevented
pulmonary
pulmonary immune response
recruitment
respiratory
SARS-CoV-2
scRNA-seq
severe disease
single-cell
Standard-of-care
subpopulation
synergistic
synergistic effects
therapeutic option
therapeutic options
Therapies
therapy
transcriptomic
transcriptomics
Treatment
Vaccine
vaccine efficacy
Vaccine hesitancy
variants
Viral
viral burden
was reduced
[DOI] 10.1016/j.ymthe.2022.03.014 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.ymthe.2022.03.014 PMC 바로가기 [Article Type] Article